• Mashup Score: 0
    Wolters Kluwer Health - 3 year(s) ago

    JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable…

    Tweet Tweets with this article
    • Osteopenia is not associated with disease location, phenotype, extent, or estimated duration of disease before diagnosis, in pediatric Crohn disease. #IBD #crohndisease #osteopenia https://t.co/KOF0z57SDt https://t.co/ByZvSulk9x

  • Mashup Score: 0

    This review discusses the diagnosis and management of Crohn disease, including the importance of disease severity and risk stratification when determining a treatment strategy, the importance of maintenance therapy, and the adverse effects of treatment options.

    Tweet Tweets with this article
    • #Crohndisease non-GI manifestations: -Arthritis (knees, hips, shoulders) -Sacroiliitis -Ankylosing spondylitis -Pyoderma gangrenosum -Erythema nodosum -Uveitis, episcleritis, scleritis -Mouth ulcers -Primary sclerosing cholangitis https://t.co/elbyBuwsj3 @ibddoctor

  • Mashup Score: 2

    This review discusses the diagnosis and management of Crohn disease, including the importance of disease severity and risk stratification when determining a treatment strategy, the importance of maintenance therapy, and the adverse effects of treatment options.

    Tweet Tweets with this article
    • #Crohndisease non-GI manifestations: -Arthritis (knees, hips, shoulders) -Sacroiliitis -Ankylosing spondylitis -Pyoderma gangrenosum -Erythema nodosum -Uveitis, episcleritis, scleritis -Mouth ulcers -Primary sclerosing cholangitis https://t.co/XF4k3O2ijO @ibddoctor

  • Mashup Score: 2

    This review discusses the diagnosis and management of Crohn disease, including the importance of disease severity and risk stratification when determining a treatment strategy, the importance of maintenance therapy, and the adverse effects of treatment options.

    Tweet Tweets with this article
    • #Crohndisease non-GI manifestations: -Arthritis (knees, hips, shoulders) -Sacroiliitis -Ankylosing spondylitis -Pyoderma gangrenosum -Erythema nodosum -Uveitis, episcleritis, scleritis -Mouth ulcers -Primary sclerosing cholangitis https://t.co/ZwRtjTs3wP @ibddoctor

  • Mashup Score: 0

    This review discusses the diagnosis and management of Crohn disease, including the importance of disease severity and risk stratification when determining a treatment strategy, the importance of maintenance therapy, and the adverse effects of treatment options.

    Tweet Tweets with this article
    • #Crohndisease non-GI manifestations: -Arthritis (knees, hips, shoulders) -Sacroiliitis -Ankylosing spondylitis -Pyoderma gangrenosum -Erythema nodosum -Uveitis, episcleritis, scleritis -Mouth ulcers -Primary sclerosing cholangitis https://t.co/oGWQJtRToP @ibddoctor

  • Mashup Score: 12

    New therapies have greatly improved outcomes for patients with Crohn disease. Peter Higgins, MD, from the University of Michigan, discusses advances in management and treatment protocols.

    Tweet Tweets with this article
    • New therapies have greatly improved outcomes for patients with #Crohndisease. Peter Higgins, MD, from the University of Michigan, discusses advances in management and treatment protocols https://t.co/2i31Nl9nPM

  • Mashup Score: 11

    This review discusses the diagnosis and management of Crohn disease, including the importance of disease severity and risk stratification when determining a treatment strategy, the importance of maintenance therapy, and the adverse effects of treatment options.

    Tweet Tweets with this article
    • #Crohndisease non-GI manifestations: -Arthritis (knees, hips, shoulders) -Sacroiliitis -Ankylosing spondylitis -Pyoderma gangrenosum -Erythema nodosum -Uveitis, episcleritis, scleritis -Mouth ulcers -Primary sclerosing cholangitis https://t.co/qGee5r6mCw @ibddoctor umichmedicine

  • Mashup Score: 5

    In the race to put existing drugs to the test for coronavirus disease 2019 (COVID-19), a National Institutes of Health–funded team winnowed down about 12 000 approved and investigational drugs to 13 promising candidates against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

    Tweet Tweets with this article
    • A high-throughput analysis of >12K agents has id'd 13 potential treatments for #SARSCoV2 which may work w remdesivir, incl clofazimine and apilimod, an investigational agent for #Crohndisease and RA https://t.co/5QZuEl8jc0